CELLTRION PHARM has ranked among the top searched stocks for 12 days in the past month.


As of 1:31 PM on the 8th, CELLTRION PHARM is trading at 217,300 KRW, down 8.23% from the previous day. This represents a 93.67% increase compared to November 10. CELLTRION PHARM is known as a company specializing in pharmaceuticals and health supplements.

Today, foreigners have sold a net 22,000 shares of CELLTRION PHARM, and institutions have sold a net 1,000 shares, according to provisional data. Over the past five days, individual investors have bought a net 169,054 shares, while foreigners and institutions have sold a net 170,801 shares and bought a net 6,255 shares, respectively.


On December 3, CELLTRION PHARM made headlines in the market with "Intraday record high... Expectations for COVID-19 treatment development."





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing